▁Sub 6.6640625
title 4.55078125
: 0.78271484375
▁Company 8.8125
▁a 7.640625
ims 1.275390625
▁to 0.1021728515625
▁revolution 4.31640625
ize 0.39697265625
▁cancer 6.5078125
▁treatment 0.84326171875
▁with 1.556640625
▁prom 7.12890625
ising 0.00759124755859375
▁drug 3.03125
▁candidates 3.712890625
<0x0A> 0.64599609375
[ 6.4140625
City 8.96875
, 3.42578125
▁Date 4.54296875
] 0.442626953125
▁- 2.408203125
▁Ch 7.3359375
iros 7.10546875
cience 0.0271453857421875
▁Group 4.3046875
▁pl 3.984375
c 0.0010576248168945312
, 1.3515625
▁a 0.299560546875
▁leading 2.703125
▁ph 3.75390625
arma 0.01190185546875
ce 0.0133819580078125
ut 1.2516975402832031e-05
ical 0.00013840198516845703
▁company 0.44287109375
, 1.7255859375
▁has 1.048828125
▁announced 0.5830078125
▁significant 5.79296875
▁progress 0.380615234375
▁in 0.1827392578125
▁their 3.404296875
▁rel 9.5234375
ent 0.02874755859375
less 0.0007491111755371094
▁purs 0.849609375
uit 0.001953125
▁of 0.422119140625
▁ground 3.560546875
bre 0.61474609375
aking 0.00011050701141357422
▁cancer 0.9091796875
▁treat 0.9208984375
ments 0.00023424625396728516
. 0.30908203125
▁Following 5.140625
▁successful 3.10546875
▁pre 1.7109375
cl 0.52978515625
in 7.998943328857422e-05
ical 0.0004086494445800781
▁studies 1.0595703125
, 0.55322265625
▁the 0.452392578125
▁company 0.26220703125
▁has 1.134765625
▁selected 4.6484375
▁two 0.92578125
▁highly 4.0078125
▁prom 0.388916015625
ising 0.0003771781921386719
▁anti 6.02734375
- 0.005687713623046875
can 0.21875
cer 0.00041747093200683594
▁comp 2.1796875
ounds 0.00946807861328125
▁for 1.1328125
▁evaluation 4.5
▁in 0.1573486328125
▁human 2.009765625
▁tri 1.3955078125
als 0.0001977682113647461
. 0.341552734375
▁This 3.2265625
▁development 2.830078125
▁holds 5.23828125
▁immense 1.970703125
▁potential 0.2218017578125
▁for 0.6904296875
▁transform 1.7177734375
ing 0.0221099853515625
▁the 0.395751953125
▁landscape 2.3828125
▁of 0.006397247314453125
▁cancer 0.08197021484375
▁ther 2.162109375
apy 0.2254638671875
. 1.7587890625
<0x0A> 0.11236572265625
Ch 1.380859375
iros 0.033599853515625
cience 0.0006628036499023438
▁Group 0.28173828125
▁pl 0.68115234375
c 6.568431854248047e-05
' 2.79296875
s 0.0002155303955078125
▁un 5.7578125
wa 0.2073974609375
ver 9.417533874511719e-06
ing 7.021427154541016e-05
▁commit 0.4140625
ment 4.661083221435547e-05
▁to 0.0283050537109375
▁adv 2.126953125
ancing 0.01444244384765625
▁scientific 3.650390625
▁understanding 3.21875
▁and 0.73486328125
▁impro 2.18359375
ving 0.00019979476928710938
▁patient 0.454833984375
▁out 0.28955078125
comes 3.8623809814453125e-05
▁fu 9.171875
els 6.651878356933594e-05
▁their 0.55712890625
▁constant 5.328125
▁search 1.943359375
▁for 0.0028553009033203125
▁novel 1.93359375
▁treatment 3.5703125
▁options 0.72412109375
. 0.0601806640625
▁By 3.177734375
▁lever 1.2236328125
aging 0.00012409687042236328
▁its 3.97265625
▁expert 1.6845703125
ise 0.012481689453125
▁in 0.329833984375
▁drug 1.640625
▁discovery 0.64306640625
▁and 0.261474609375
▁development 0.184326171875
, 0.0163421630859375
▁the 0.15771484375
▁company 0.01398468017578125
▁has 1.0068359375
▁successfully 3.80078125
▁identified 0.198486328125
▁two 0.439208984375
▁comp 1.5634765625
ounds 0.0025959014892578125
▁demonstr 6.2890625
ating 0.0001399517059326172
▁exception 2.353515625
al 0.002819061279296875
▁effic 1.5576171875
acy 2.4318695068359375e-05
▁against 1.2333984375
▁various 1.1103515625
▁can 3.6796875
cers 0.00017702579498291016
▁during 8.1796875
▁pre 0.259033203125
cl 0.038421630859375
in 3.993511199951172e-05
ical 6.902217864990234e-05
▁testing 1.712890625
▁phases 6.46484375
. 0.1658935546875
<0x0A> 0.69873046875
The 1.060546875
▁first 1.5419921875
▁comp 0.58740234375
ound 0.00018024444580078125
, 0.5625
▁scientific 11.515625
ally 0.00982666015625
▁l 6.16015625
abeled 0.0001354217529296875
▁CS 2.13671875
- 0.8564453125
1 1.2919921875
0 1.0634765625
0 1.060546875
9 2.73046875
7 4.48828125
, 0.41015625
▁has 0.99755859375
▁shown 0.95751953125
▁remarkable 1.1640625
▁potential 1.9677734375
▁in 0.60009765625
▁select 5.96484375
ively 0.3681640625
▁target 0.720703125
ing 0.0003228187561035156
▁and 1.818359375
▁neutral 4.69140625
izing 0.006351470947265625
▁solid 5.69140625
▁tum 0.09161376953125
ors 0.365478515625
, 1.53125
▁particularly 3.23828125
▁those 0.93896484375
▁resist 2.185546875
ant 0.004024505615234375
▁to 0.0107574462890625
▁conventional 1.0068359375
▁treat 1.64453125
ments 1.7523765563964844e-05
. 0.269287109375
▁During 3.671875
▁animal 3.56640625
▁studies 1.1845703125
, 0.0885009765625
▁CS 0.7060546875
- 0.0010833740234375
1 0.001926422119140625
0 0.0005164146423339844
0 0.0011997222900390625
9 0.0013675689697265625
7 0.0022296905517578125
▁displayed 2.103515625
▁robust 4.09765625
▁in 3.197265625
hib 0.037628173828125
ition 0.8017578125
▁of 0.08758544921875
▁tum 0.5498046875
or 0.021270751953125
▁growth 0.193359375
, 1.201171875
▁leading 2.501953125
▁to 0.037811279296875
▁complete 1.8837890625
▁rem 2.2265625
ission 0.017303466796875
▁in 0.1334228515625
▁a 2.658203125
▁significant 0.70849609375
▁proportion 1.5244140625
▁of 0.0016431808471679688
▁treated 1.7333984375
▁subjects 2.490234375
. 0.078125
▁This 2.205078125
▁encourag 3.078125
ing 0.007328033447265625
▁result 1.4677734375
▁positions 5.76171875
▁the 1.6591796875
▁comp 0.438720703125
ound 0.00027441978454589844
▁as 0.1478271484375
▁a 0.10015869140625
▁strong 3.12109375
▁candidate 0.275634765625
▁for 0.01108551025390625
▁further 1.0810546875
▁evaluation 1.0458984375
▁in 0.10308837890625
▁human 0.49853515625
▁tri 0.309814453125
als 1.2874603271484375e-05
. 0.13037109375
<0x0A> 0.00824737548828125
The 0.408203125
▁second 0.066650390625
▁comp 0.140380859375
ound 4.374980926513672e-05
, 0.073486328125
▁known 3.19140625
▁as 0.0211944580078125
▁CS 0.0296783447265625
- 0.0051116943359375
1 0.281005859375
2 3.083984375
9 2.90234375
8 2.4140625
3 2.486328125
, 0.02728271484375
▁exhib 2.458984375
its 0.2386474609375
▁a 2.404296875
▁unique 0.51123046875
▁mechanism 0.389404296875
▁of 0.0051422119140625
▁action 0.003986358642578125
▁in 4.37890625
▁dis 4.26953125
m 4.5390625
ant 0.00016772747039794922
ling 6.783008575439453e-05
▁the 1.4130859375
▁intr 5.05859375
icate 0.171630859375
▁structures 2.7578125
▁of 0.5703125
▁blood 5.7734375
▁can 4.4609375
cers 0.0004680156707763672
▁such 1.91015625
▁as 6.699562072753906e-05
▁le 0.87939453125
uk 0.0164031982421875
emia 0.08941650390625
▁and 0.61962890625
▁l 0.2318115234375
ym 1.2159347534179688e-05
ph 8.463859558105469e-06
oma 0.0396728515625
. 0.09814453125
▁Initial 6.3046875
▁investig 5.35546875
ations 0.00435638427734375
▁suggest 2.279296875
▁that 0.1065673828125
▁CS 0.53662109375
- 0.0007038116455078125
1 0.0007658004760742188
2 0.0011339187622070312
9 0.0012865066528320312
8 0.0007696151733398438
3 0.0012121200561523438
▁dis 5.81640625
rupt 0.08544921875
s 0.0002617835998535156
▁cancer 3.86328125
▁cell 1.080078125
▁surv 2.599609375
ival 0.002960205078125
▁path 1.5771484375
ways 0.00572967529296875
, 0.67333984375
▁offering 6.45703125
▁a 0.6767578125
▁potential 2.75390625
▁break 3.125
through 0.00028324127197265625
▁for 1.95703125
▁patients 0.62451171875
▁with 0.75244140625
▁limited 3.634765625
▁treatment 0.280517578125
▁options 0.0162811279296875
. 0.0289459228515625
▁Animal 7.9453125
▁studies 0.22412109375
▁have 0.49365234375
▁demonstrated 1.5361328125
▁un 5.73828125
pre 0.75830078125
ced 2.09808349609375e-05
ented 0.0010623931884765625
▁effic 0.57666015625
acy 9.5367431640625e-06
▁in 1.2978515625
▁reducing 1.9716796875
▁tum 0.291015625
or 0.018768310546875
▁bur 0.58251953125
den 0.01293182373046875
, 1.0615234375
▁making 4.40234375
▁CS 0.552734375
- 0.0005307197570800781
1 0.0006580352783203125
2 0.0010013580322265625
9 0.00021791458129882812
8 0.0007534027099609375
3 0.0006184577941894531
▁a 0.4580078125
▁remarkable 5.296875
▁prospect 2.6953125
▁in 3.13671875
▁the 0.43017578125
▁fight 0.65185546875
▁against 0.00034332275390625
▁h 3.107421875
emat 0.0007266998291015625
ological 0.26513671875
▁m 0.27001953125
align 2.7418136596679688e-06
an 0.006053924560546875
cies 0.0008563995361328125
. 0.005558013916015625
<0x0A> 0.0042724609375
Dr 4.32421875
. 0.060638427734375
▁K 4.66015625
atherine 3.37890625
▁Nelson 7.2734375
, 0.059600830078125
▁Chief 1.123046875
▁Scient 0.88232421875
ific 0.024444580078125
▁Officer 0.0095062255859375
▁at 0.56298828125
▁Ch 0.00441741943359375
iros 0.00096893310546875
cience 6.67572021484375e-05
▁Group 0.022430419921875
▁pl 0.09588623046875
c 2.09808349609375e-05
, 0.02874755859375
▁expressed 1.8857421875
▁her 0.485595703125
▁excitement 0.7958984375
▁about 0.8193359375
▁these 1.751953125
▁select 9.6015625
▁comp 0.8427734375
ounds 0.002857208251953125
, 0.8330078125
▁saying 2.89453125
, 0.235107421875
▁" 0.05218505859375
The 2.83203125
▁potential 2.4609375
▁of 0.39794921875
▁CS 1.1640625
- 0.0011043548583984375
1 0.0009326934814453125
0 0.038330078125
0 0.0005121231079101562
9 0.0005507469177246094
7 0.00099945068359375
▁and 0.02581787109375
▁CS 0.0005660057067871094
- 0.0005116462707519531
1 0.0006933212280273438
2 0.0005631446838378906
9 0.0007925033569335938
8 0.0007944107055664062
3 0.0003371238708496094
▁cannot 5.9140625
▁be 0.0003478527069091797
▁over 0.0880126953125
st 0.01233673095703125
ated 3.933906555175781e-06
. 0.1806640625
▁They 2.765625
▁represent 1.3115234375
▁a 0.416748046875
▁significant 1.1982421875
▁step 1.076171875
▁forward 0.03668212890625
▁in 0.037994384765625
▁target 7.17578125
ed 0.421630859375
▁cancer 0.2266845703125
▁ther 0.258544921875
ap 2.6953125
ies 8.869171142578125e-05
▁and 1.4755859375
▁hold 1.4580078125
▁the 2.322265625
▁promise 0.180908203125
▁to 2.599609375
▁res 5.78125
hape 0.0002694129943847656
▁the 0.36083984375
▁treatment 1.76171875
▁landscape 0.1201171875
▁for 0.52978515625
▁patients 1.224609375
▁batt 4.19140625
ling 0.0001647472381591797
▁various 1.9716796875
▁m 3.18359375
align 8.106231689453125e-06
an 0.0200958251953125
cies 4.291534423828125e-06
." 0.63720703125
<0x0A> 0.0654296875
With 2.80859375
▁the 1.6767578125
▁selection 1.41796875
▁of 0.0034694671630859375
▁these 0.1649169921875
▁two 0.82080078125
▁comp 0.7333984375
ounds 0.0004494190216064453
▁for 1.80078125
▁human 1.1181640625
▁tri 0.2022705078125
als 6.103515625e-05
, 0.0157623291015625
▁Ch 0.0672607421875
iros 0.0005164146423339844
cience 6.031990051269531e-05
▁Group 0.0022792816162109375
▁pl 0.0158843994140625
c 9.894371032714844e-06
▁is 1.0244140625
▁emb 4.7578125
ark 0.034332275390625
ing 9.632110595703125e-05
▁on 0.0015506744384765625
▁the 3.966796875
▁next 0.110595703125
▁critical 2.83203125
▁phase 0.5068359375
▁of 0.26611328125
▁drug 2.291015625
▁development 0.08343505859375
. 0.3720703125
▁R 8.4765625
ig 0.060821533203125
orous 0.0014190673828125
▁testing 1.916015625
▁on 5.4609375
▁human 1.7890625
▁subjects 0.177001953125
▁will 0.380615234375
▁assess 3.61328125
▁the 0.268310546875
▁safety 0.481689453125
, 1.1826171875
▁toler 0.7373046875
ability 0.015411376953125
, 0.014434814453125
▁and 0.0161590576171875
▁effic 0.1171875
acy 2.5033950805664062e-06
▁of 0.003200531005859375
▁the 0.66015625
▁comp 0.3515625
ounds 0.0009374618530273438
, 0.58837890625
▁opening 5.60546875
▁doors 3.751953125
▁to 0.51611328125
▁potential 0.708984375
▁regul 3.595703125
atory 4.1484832763671875e-05
▁appro 0.02020263671875
val 2.2172927856445312e-05
▁and 0.5478515625
▁subsequent 3.97265625
▁avail 2.716796875
ability 0.0001690387725830078
▁for 1.2412109375
▁patients 0.80322265625
. 0.9892578125
<0x0A> 0.2318115234375
To 5.13671875
▁ensure 1.3681640625
▁the 0.95654296875
▁highest 0.70849609375
▁standards 0.546875
▁of 0.115966796875
▁patient 2.306640625
▁care 1.0732421875
▁and 1.1884765625
▁regul 5.3828125
atory 1.5854835510253906e-05
▁comp 0.03033447265625
liance 0.00041675567626953125
, 0.02587890625
▁Ch 0.5048828125
iros 0.00038313865661621094
cience 0.0001112222671508789
▁Group 0.00347900390625
▁pl 0.01221466064453125
c 3.802776336669922e-05
▁will 2.630859375
▁collabor 2.0703125
ate 0.00017452239990234375
▁with 0.1351318359375
▁ren 1.7724609375
owned 3.325939178466797e-05
▁on 3.107421875
col 0.33544921875
ogy 4.649162292480469e-06
▁cent 0.9267578125
ers 0.00823974609375
▁and 0.7060546875
▁vision 12.4375
ary 0.042633056640625
▁clin 1.716796875
ical 0.91943359375
▁investig 0.98681640625
ators 0.0014524459838867188
▁across 3.3515625
▁the 0.55126953125
▁country 3.88671875
. 0.11370849609375
▁T 4.046875
ogether 0.00800323486328125
, 0.0196990966796875
▁they 0.607421875
▁will 0.20751953125
▁design 2.818359375
, 3.689453125
▁execute 1.279296875
, 0.021392822265625
▁and 0.010345458984375
▁analyze 0.57080078125
▁the 0.7109375
▁human 2.98046875
▁tri 0.1845703125
als 3.933906555175781e-06
▁met 7.203125
icul 2.2411346435546875e-05
ously 2.288818359375e-05
, 0.303466796875
▁gather 3.93359375
ing 0.0020732879638671875
▁in 2.58203125
valu 0.0762939453125
able 2.1219253540039062e-05
▁data 0.6435546875
▁to 1.1015625
▁inform 1.4248046875
▁future 0.397216796875
▁treatment 1.9677734375
▁strateg 0.53271484375
ies 8.344650268554688e-07
. 0.263427734375
<0x0A> 0.048187255859375
Cons 7.5
ider 0.441162109375
ing 0.036895751953125
▁the 0.1201171875
▁immense 4.171875
▁potential 0.41748046875
▁and 3.568359375
▁hope 7.05859375
▁these 1.0927734375
▁comp 0.587890625
ounds 0.0006208419799804688
▁hold 0.80126953125
, 1.6142578125
▁exper 7.29296875
ts 0.00018656253814697266
▁and 3.0234375
▁patient 4.16015625
▁advoc 0.10321044921875
ates 0.257080078125
▁in 4.4375
▁the 0.044097900390625
▁field 1.0654296875
▁are 1.3076171875
▁deeply 5.81640625
▁optim 1.01171875
istic 2.6702880859375e-05
▁about 0.32177734375
▁the 0.4140625
▁progress 3.423828125
▁being 1.2021484375
▁made 0.0034465789794921875
▁by 1.5400390625
▁Ch 0.041534423828125
iros 0.00022876262664794922
cience 2.491474151611328e-05
▁Group 0.0024700164794921875
▁pl 0.008758544921875
c 1.704692840576172e-05
. 0.10321044921875
▁The 1.806640625
▁selection 2.80859375
▁of 0.0126953125
▁CS 1.06640625
- 0.00017964839935302734
1 0.0003502368927001953
0 0.0019435882568359375
0 0.00016009807586669922
9 0.0001685619354248047
7 0.0005297660827636719
▁and 0.002285003662109375
▁CS 0.0002524852752685547
- 0.00027489662170410156
1 0.0004963874816894531
2 0.0002313852310180664
9 0.000438690185546875
8 0.0004818439483642578
3 0.000194549560546875
▁for 0.3623046875
▁human 0.356201171875
▁tri 0.06634521484375
als 8.702278137207031e-06
▁sign 4.609375
ifies 0.003246307373046875
▁a 0.1593017578125
▁major 2.388671875
▁step 1.7421875
▁forward 0.1456298828125
, 4.84765625
▁inst 7.8515625
illing 0.01013946533203125
▁confidence 1.0244140625
▁in 0.59423828125
▁the 0.1312255859375
▁possibilities 5.12890625
▁these 3.94140625
▁comp 0.861328125
ounds 0.00023353099822998047
▁may 1.2421875
▁offer 1.33203125
▁in 1.7890625
▁the 1.025390625
▁fight 0.344970703125
▁against 0.0006837844848632812
▁cancer 0.0247955322265625
. 0.006984710693359375
<0x0A> 0.175048828125
As 1.654296875
▁Ch 1.9111328125
iros 0.0005426406860351562
cience 2.0623207092285156e-05
▁Group 0.0016450881958007812
▁pl 0.005542755126953125
c 1.0013580322265625e-05
▁moves 2.193359375
▁closer 1.7958984375
▁to 0.07647705078125
▁the 2.25
▁human 4.19140625
▁tri 0.34228515625
als 6.473064422607422e-05
▁phase 0.56201171875
, 0.07366943359375
▁the 0.91259765625
▁entire 4.5
▁medical 2.908203125
▁community 0.1265869140625
▁eager 1.46875
ly 6.377696990966797e-05
▁a 0.1409912109375
wa 2.384185791015625e-06
its 3.814697265625e-06
▁the 0.09027099609375
▁results 1.30859375
. 1.4384765625
▁The 1.1787109375
▁company 1.6572265625
' 0.67529296875
s 8.225440979003906e-05
▁t 3.15625
ire 0.1114501953125
less 0.00011670589447021484
▁purs 1.359375
uit 0.0006546974182128906
▁of 0.0301513671875
▁solutions 6.3984375
▁to 0.85546875
▁combat 3.95703125
▁cancer 0.3984375
▁opens 9.6875
▁up 1.13671875
▁new 0.97119140625
▁a 1.259765625
ven 0.0001938343048095703
ues 3.5762786865234375e-07
▁of 1.1103515625
▁hope 0.216552734375
▁and 1.5576171875
▁insp 3.1171875
ires 0.42626953125
▁renew 3.0703125
ed 0.0001367330551147461
▁determ 3.166015625
ination 1.1920928955078125e-07
▁in 0.44775390625
▁the 0.09283447265625
▁battle 1.59765625
▁against 0.0263671875
▁this 0.1954345703125
▁dead 2.39453125
ly 0.0004532337188720703
▁disease 0.01340484619140625
. 0.005718231201171875
<0x0A> 0.501953125
Dis 4.9140625
cla 0.2484130859375
imer 1.71661376953125e-05
: 0.032470703125
▁The 1.2265625
▁content 2.306640625
▁of 0.4638671875
▁this 0.09375
▁press 0.75341796875
▁release 0.003200531005859375
▁is 0.284423828125
▁not 2.509765625
▁intended 0.2484130859375
▁to 0.124267578125
▁be 0.2998046875
▁a 0.37109375
▁substitute 0.2734375
▁for 0.004119873046875
▁professional 0.116455078125
▁medical 0.04833984375
▁advice 0.01276397705078125
, 0.162841796875
▁diagn 0.00560760498046875
osis 0.0006580352783203125
, 0.0977783203125
▁or 0.0026950836181640625
▁treatment 0.00017654895782470703
. 0.0240325927734375
▁Always 0.088623046875
▁seek 0.025665283203125
▁the 0.0181884765625
▁advice 0.0007028579711914062
▁of 0.0015306472778320312
▁your 0.337646484375
▁phys 0.0543212890625
ician 0.00011277198791503906
▁or 0.025909423828125
▁other 0.07257080078125
▁qualified 0.001346588134765625
▁health 0.0035419464111328125
▁provider 0.69921875
▁with 0.117919921875
▁any 0.005153656005859375
▁questions 0.0017347335815429688
▁you 0.037353515625
▁may 0.01123809814453125
▁have 0.0003235340118408203
▁regarding 0.003940582275390625
▁a 0.041351318359375
▁medical 0.01078033447265625
▁condition 0.004726409912109375
. 0.09356689453125
